Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Baxter International Inc. (NYSE:BAX) today announced solid financial results for the second quarter, with earnings that exceeded the company’s previously issued guidance, and confirmed its full-year 2013 financial outlook.
For the second quarter, Baxter reported net income of $590 million and earnings per diluted share of $1.07, compared to net income of $661 million and earnings per diluted share of $1.19 in the same period last year.
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
